Adverum Biotechnologies logo
Adverum Biotechnologies ADVM

Quarterly report 2025-Q3
added 05-30-2026

report update icon

Adverum Biotechnologies Cash Conversion Cycle 2011-2026 | ADVM

Quarterly Cash Conversion Cycle Adverum Biotechnologies

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 87.5 166 205 263 230 42.7 43 202 101 1.8 3.58 2.7 12.2 - 24.3 2.43 - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
263 1.8 92.4

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
3.11 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
-3.12 K - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
459 - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-101 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
1.73 - - $ 2.17 B usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 49.8 -0.86 % $ 4.48 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Celyad Oncology SA Celyad Oncology SA
CYAD
-55.7 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
214 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
-3.74 K $ 31.27 4.37 % $ 2.08 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-2.15 K - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
192 $ 14.72 - $ 211 M usaUSA
Advaxis Advaxis
ADXS
-82.3 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
-981 $ 0.67 -6.8 % $ 30.6 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.15 - $ 655 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-1.55 K - -0.23 % $ 916 M usaUSA